Leading clinical pharmacogenomics implementation: Advancing pharmacy practice

American Journal of Health-System Pharmacy

Volumn 72, Issue 15, 2015, Pages 1324-1328

  Johnson, Samuel G ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

CLINICAL PRACTICE; CONSENSUS; EPILEPSY; HEALTH CARE PLANNING; HEALTH EDUCATION; HUMAN; NEOPLASM; NOTE; PHARMACOGENOMICS; PHARMACY; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM; PHARMACOGENETICS; PROFESSIONAL STANDARD; PROGRAM DEVELOPMENT; TRENDS; UNITED STATES;

HUMANS; PHARMACEUTICAL SERVICES; PHARMACOGENETICS; PROFESSIONAL ROLE; PROGRAM DEVELOPMENT; UNITED STATES;

EID: 84957614568     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp140613     Document Type: Note

References (30)

1. Ganesh SK, Arnett DK, Assimes TL et al. Genetics and genomics for the prevention and treatment of cardiovascular disease: update: A scientific statement from the American Heart Association. Circulation. 2013; 128:2813-51.
2. Voora D, McLeod HL, Eby C, Gage BF. The pharmacogenetics of couma- rin therapy. Pharmacogenomics. 2005; 6:503-13.
3. Walko CM, McLeod HL. Personalizing medicine in geriatric oncology. J Clin Oncol. 2014; 32:2581-6.
4. Chan A, Pirmohamed M, Comabella M. Pharmacogenomics in neurology: current state and future steps. Ann Neurol. 2011;70:684-97.
5. Pirmohamed M, Burnside G, Eriksson N et al. A randomized trial of genotype- guided dosing of warfarin. N Engl J Med. 2013; 369:2294-303.
6. Mega JL, Simon T, Collet JP et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: A meta-analysis. JAMA. 2010; 304:1821-30.
7. Relling MV, Hancock ML, Boyett JM et al. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood. 1999; 93:2817-23.
8. Adam de Beaumais T, Fakhoury M, Medard Y et al. Determinants of mer- captopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol. 2011; 71:575-84.
9. The consensus of the Pharmacy Practice Model Summit. Am J Health-Syst Pharm. 2011;68:1148-52.
10. American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in clinical pharmacogenomics. Am J Health-Syst Pharm. 2015; 72:579-81.
11. Tipton JA. Pharmacy policies and practices: new challenges require new strategies. In: Zellmer WA, ed. Pharmacy forecast 2015-2019: strategic planning advice for pharmacy departments in hospitals and health systems. Bethesda, MD: ASHP Research and Education Foundation; 2015:30-2.
12. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2013. Am J Health- Syst Pharm. 2014; 71:924-42.
13. Williams MS. Genomic medicine implementation: learning by example. Am J Med Genet C Semin Med Genet. 2014; 166C:8-14.
14. Schildcrout JS, Denny JC, Bowton E et al. Optimizing drug outcomes through pharmacogenetics: A case for preemptive genotyping. Clin Pharmacol Ther. 2012; 92:235-42.
15. Van Driest SL, Shi Y, Bowton EA et al. Clinically actionable genotypes among 10, 000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95:423-31.
16. Hoffman JM, Haidar CE, Wilkinson MR et al. PG4KDS: A model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet. 2014; 166C:45-55.
17. Dunnenberger HM, Crews KR, Hoffman JM et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol. 2015; 55:89-106.
18. Bell GC, Crews KR, Wilkinson MR et al. Development and use of active clinical decision support for preemptive pharmacogenomics. I Am Med Inform Assoc. 2014; 21(e1):e93-9.
19. Burke W, Appelbaum P, Dame L et al. The translational potential of research on the ethical, legal, and social implications of genomics. Genet Med. 2015; 17:12-20.
20. Caudle KE, Klein TE, Hoffman JM et al. Incorporation of pharmacogenomics into routine clinical practice: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab. 2014; 15:209-17.
21. Accreditation Council for Pharmacy Education. Accreditation standards and key elements for the professional program in pharmacy leading to the doctor of pharmacy degree (released February 2, 2015). www.acpe-accredit.org/pdf/GuidanceforStandards2016FINAL.pdf (accessed 2015 Feb 20).
22. Berger AC, Johnson SG, Beachy SH et al. Improving genetics education in graduate and continuing health professional education: workshop summary, www.nap.edu/catalog/18992/improving-genetics-education-in-graduate-and-continuing-health-professional-education (accessed 2015 Feb 20).
23. Smith M, Halvorson G, Kaplan G. What's needed is a health care system that learns: recommendations from an IOM report. JAMA. 2012; 308:1637-8.
24. Weitzel KW, Elsey AR, Langaee TY et al. Clinical pharmacogenetics implementation: Approaches, successes, and challenges. Am J Med Genet C Semin Med Genet. 2014; 166C:56-67.
25. Evans WE. Culture trumps strategy: we must encourage the next generation of pharmacists to keep looking over the horizon and not be limited by what they can see today. J Am Pharm Assoc (2003). 2012; 52:450-3.
26. Relling MV, Altman RB, Goetz MP, Evans WE. Clinical implementation of pharmacogenomics: overcoming genetic excep- Tionalism. Lancet Oncol. 2010; 11:507-9.
27. Green MJ, Botkin JR. "Genetic exception- Alism" in medicine: clarifying the differ-ences between genetic and nongenetic tests. Ann Intern Med. 2003; 138:571-5.
28. Ratain MJ, Johnson JA. Meaningful use of pharmacogenetics. Clin Pharmacol Ther. 2014; 96:650-2.
29. Owusu-Obeng A, Weitzel KW, Hatton RC et al. Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy. 2014; 34:1102-12.
30. Schully SD, Lam TK, Dotson WD et al. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genet Med. 2015; 17:63-7.